Vistagen Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Vistagen Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q1 2011 to Q2 2024.
  • Vistagen Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 27.1M shares, a 243% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 27.1M +19.2M +243% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 27M +19.7M +269% Mar 31, 2024 10-Q 2024-08-13
Q4 2023 27M -180M -86.9% Dec 31, 2023 10-Q 2024-02-13
Q3 2023 12M -195M -94.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 7.88M -199M -96.2% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 7.32M +426K +6.19% Mar 31, 2023 10-K 2024-06-11
Q4 2022 207M +407K +0.2% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 207M +10.4M +5.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 207M +26.1M +14.4% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 6.89M -174M -96.2% Mar 31, 2022 10-K 2023-06-28
Q4 2021 207M +67.8M +48.9% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 197M +122M +165% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 181M +125M +223% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 181M +131M +266% Mar 31, 2021 10-K 2022-06-23
Q4 2020 139M +94.6M +214% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 74.1M +31.4M +73.4% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 55.9M +13.2M +30.8% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 49.3M +6.59M +15.4% Mar 31, 2020 10-K 2021-06-29
Q4 2019 44.2M +13M +41.7% Dec 31, 2019 10-Q 2020-02-13
Q3 2019 42.8M +14.1M +49.1% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 42.8M +19.5M +84.2% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 42.8M +19.7M +85.4% Mar 31, 2019 10-K 2020-06-30
Q4 2018 31.2M +8.48M +37.3% Dec 31, 2018 10-Q 2019-02-12
Q3 2018 28.7M +16.9M +144% Sep 30, 2018 10-Q 2018-10-29
Q2 2018 23.2M +13.8M +146% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 23.1M +14.1M +157% Mar 31, 2018 10-K 2019-06-25
Q4 2017 22.7M +14M +161% Dec 31, 2017 10-Q 2018-02-12
Q3 2017 11.8M +3.36M +40% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 9.44M +1.33M +16.4% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 8.97M +6.35M +242% Mar 31, 2017 10-K 2018-06-26
Q4 2016 8.72M +6.75M +344% Dec 31, 2016 10-Q 2017-02-13
Q3 2016 8.41M +6.54M +350% Sep 30, 2016 10-Q 2016-11-15
Q2 2016 8.11M +6.38M +369% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 2.62M +946K +56.4% Mar 31, 2016 10-K 2017-06-29
Q4 2015 1.97M +504K +34.5% Dec 31, 2015 10-Q 2016-02-16
Q3 2015 1.87M +447K +31.5% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 1.73M -26.5M -93.9% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 1.68M +367K +28% Mar 31, 2015 10-K 2016-06-24
Q4 2014 1.46M -23.8M -94.2% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 1.42M -23.1M -94.2% Sep 30, 2014 10-Q 2014-11-19
Q2 2014 28.2M +4.28M +17.9% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 1.31M 0 0% Mar 31, 2014 10-K 2015-06-29
Q4 2013 25.3M +3.23M +14.6% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 24.5M +4.48M +22.3% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 23.9M +6.38M +36.3% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 1.31M -22.2M -94.4% Mar 31, 2013 10-Q 2014-11-19
Q4 2012 22.1M +3.55M +19.2% Dec 31, 2012 10-Q 2013-02-14
Q3 2012 20.1M Sep 30, 2012 10-Q 2012-11-14
Q2 2012 17.6M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 23.5M +18.2M +348% Mar 31, 2012 10-Q 2013-11-14
Q4 2011 18.5M Dec 31, 2011 10-Q 2012-02-14
Q1 2011 5.24M Mar 31, 2011 10-K 2012-07-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.